483 RESPONSE
Eli Lilly & CompanyEli Lilly & Company – FDA 483 Response, Mar 16, 2021
Record Details
This 483 RESPONSE record concerns Eli Lilly & Company, with an inspection on March 16, 2021, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.
View Company Profile
ID · 48bca0f9-fb52-4f51-9e65-4d0fd6283a21
Violation Codes1
21 CFR 210
Full citation text and observation details available on the Dashboard.
Other documents for Eli Lilly & Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.